Methotrexate reduces withdrawal rates of TNF inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive.

Greenwood, Mandy; Shipa, Muhammad; Yeoh, Su-Ann; Roussou, Euthalia; Mukerjee, Dev; Ehrenstein, Michael R

Greenwood, Mandy; Shipa, Muhammad; Yeoh, Su-Ann; Roussou, Euthalia; Mukerjee, Dev; Ehrenstein, Michael R.

Afiliação

Greenwood M; Centre for Rheumatology, UCL, London, UK.
Shipa M; Centre for Rheumatology, UCL, London, UK.
Yeoh SA; Centre for Rheumatology, UCL, London, UK.
Roussou E; Rheumatology Department, Barking Havering and Redbridge University Hospitals NHS Trust, Romford, Essex, UK.
Mukerjee D; Rheumatology Department, North Middlesex University Hospital NHS Trust, London, UK.
Ehrenstein MR; Centre for Rheumatology, UCL, London, UK m.ehrenstein@ucl.ac.uk.

Ann Rheum Dis ; 79(11): 1516-1517, 2020 11.

Article em En | MEDLINE | ID: mdl-32467248

Assuntos

Artrite Reumatoide/sangue; Artrite Reumatoide/tratamento farmacológico; Imunossupressores/uso terapêutico; Metotrexato/uso terapêutico; Inibidores do Fator de Necrose Tumoral/uso terapêutico; Adalimumab/uso terapêutico; Anticorpos Antiproteína Citrulinada/sangue; Etanercepte/uso terapêutico; Humanos; Estudos Retrospectivos; Fator Reumatoide/sangue; Resultado do Tratamento

Palavras-chave

anti-citrullinated protein antibodies; arthritis, rheumatoid; methotrexate; rheumatoid factor; tumor necrosis factor inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Metotrexato / Inibidores do Fator de Necrose Tumoral / Imunossupressores Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google